Clinical Trials Logo

Clinical Trial Summary

The investigators will investigate the safety and preliminary efficacy of ISDN therapy to reduce venous congestion and improve exercise tolerance in children and adults after the Fontan operation. This will be accomplished by recruiting 15 Fontan physiology patients from the Cincinnati Children's Fontan clinic and University of Kentucky Pediatric Cardiology clinic for the investigation. The investigators will non-invasively measure both central venous pressures at rest and during graded cardiopulmonary exercise testing. In addition the study team will obtain a measurement of liver stiffness before and after a 4-week regimen of ISDN therapy. Patients will be seen twice in clinic, once before and after ISDN therapy, and phone calls will be made to ensure safety, compliance, and make appropriate alterations to medications throughout the study period. Pre- and post-intervention central venous pressure and exercise tolerance will be compared.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04297241
Study type Interventional
Source Children's Hospital Medical Center, Cincinnati
Contact
Status Completed
Phase Phase 2
Start date December 12, 2019
Completion date May 3, 2021

See also
  Status Clinical Trial Phase
Completed NCT02946892 - Effect of Carvedilol on Exercise Performance in Fontan Patients Phase 4
Completed NCT03965351 - TRPV2 Agonists in the Fontan Circulation Phase 4
Withdrawn NCT01607983 - Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients Phase 3
Not yet recruiting NCT04288596 - Canadian Adult Congenital Heart Disease Intervention Registry